Press Releases
Pfizer and BioNTech Announce an Agreement with U.S. Government...
Pfizer Inc. and BioNTech SE announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense...
Press Releases
Bavarian Nordic and AdaptVac Sign Final License Agreement on...
Bavarian Nordic announced the signing of an agreement with AdaptVac, a joint venture established by ExpreS2ion Biotechnologies and NextGen Vaccines spun out of the University...
Drug Research
BioInvent’s BI-1206 could improve treatment in several cancers
Alexander Eggermont, MD, PhD, Chief Scientific Officer at the Princess Máxima Center and renowned expert in immunotherapy showcased the broad potential of BI-1206 in enhancing...
Clinical Trials
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic...
Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of COVID-19...
Press Releases
Vesigen Therapeutics launches with USD 28.5 million Series A...
Vesigen Therapeutics launched with the objective to overcome the hurdle of targeted intracellular drug delivery of next-generation therapeutics, such as CRISPR-cas9, RNA molecules and other...
Clinical Trials
Biogen Plans to Initiate Phase 4 Study Evaluating Benefit...
Biogen Inc announced it plans to initiate a global Phase 4 clinical study, RESPOND, to examine the clinical benefit and assess the safety of SPINRAZA®...
Drug Research
Catalent Biologics to Invest $30 Million to Create European...
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.